Search results
Has Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) Impressive Stock Performance Got Anything to Do...
Simply Wall St. via Yahoo Finance· 6 hours agoProtagonist Therapeutics (NASDAQ:PTGX) has had a great run on the share market with its stock up by...
Insider Selling: Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Director Sells 231,548 Shares of Stock
ETF DAILY NEWS· 15 hours agoKaryopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) Director Deepika Pakianathan sold 231,548 shares of the company’s stock in a transaction that ...
StockNews.com Downgrades ProQR Therapeutics (NASDAQ:PRQR) to Sell
ETF DAILY NEWS· 3 days agoProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was downgraded by investment analysts at...
Halozyme Therapeutics (NASDAQ:HALO) Updates FY24 Earnings Guidance
ETF DAILY NEWS· 13 hours agoHalozyme Therapeutics (NASDAQ:HALO – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance ...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives Average Recommendation of “Moderate Buy” from...
ETF DAILY NEWS· 17 hours agoShares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) have received an average rating of “Moderate Buy” from the five research firms that ...
Enliven Therapeutics (NASDAQ:ELVN) Trading 8.2% Higher
ETF DAILY NEWS· 16 hours agoEnliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s stock price traded up 8.2% during mid-day trading on Friday . The stock traded as high as $21.85 ...
Galectin Therapeutics (NASDAQ:GALT) Stock Price Crosses Above Two Hundred Day Moving Average of...
ETF DAILY NEWS· 12 hours agoShares of Galectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a ...
CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 0.5%
ETF DAILY NEWS· 15 hours agoShares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 0.5% on Friday . The stock traded as low as $58.01 and last traded at $59.66. 293,738 ...
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
Motley Fool via Yahoo Finance· 9 hours agoStructure Therapeutics (NASDAQ: GPCR) might have something cooking that could one day unseat the...
It Looks Like Intellia Therapeutics, Inc.'s (NASDAQ:NTLA) CEO May Expect Their Salary To Be Put...
Simply Wall St. via Yahoo Finance· 3 days ago(NASDAQ:NTLA) recently. Shareholders will be interested in what the board will have to say about...